Pathway Genomics is a biotechnology company focused on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/05/2016 | Series E-1 | $40MM | $xx.xx | $932.69MM | International Business Machines | |
Price per Share
$xx.xx
Shares Outstanding
4,210,526
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
International Business Machines
|
||||||
11/12/2014 | Series D | $35.78MM | $xx.xx | $470MM | International Business Machines | |
Price per Share
$xx.xx
Shares Outstanding
7,156,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
International Business Machines
|
||||||
04/01/2014 | Series C | $36.51MM | $xx.xx | $185MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
17,140,800
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/15/2009 | Series B | $11.75MM | $xx.xx | $72.48MM | Edelson Technology Partners, Founders Fund, Korea-Seoul Life Science Fund, Western Technology Investment | |
Price per Share
$xx.xx
Shares Outstanding
18,813,038
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Edelson Technology Partners, Founders Fund, Korea-Seoul Life Science Fund, Western Technology Investment
|
||||||
07/01/2009 | Series A | $3.19MM | $xx.xx | $14MM | Edelson Technology Partners, Founders Fund, Western Technology Investment | |
Price per Share
$xx.xx
Shares Outstanding
11,963,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Edelson Technology Partners, Founders Fund, Western Technology Investment
|